A novel germline CACNA1H mutation (p.Tyr613Phe), predicted to be damaging, was identified in a patient with unilateral adrenal hyperplasia and primary aldosteronism.
Case Report (n=1)
Identifies a novel CACNA1H mutation in primary aldosteronism, expanding the genetic spectrum of the disease and supporting genetic sequencing for unclear etiologies.
Background: Primary aldosteronism (PA) is an endocrine disorder characterized by the autonomous, excessive production of aldosterone from the adrenal glands. Familial hyperaldosteronism (FH) is one type of PA. FH is further subclassified into types I through IV according to different gene mutations. Case presentation: This paper reports a case of unilateral adrenal hyperplasia with germline CACNA1H mutation, p.His515Tyr and p.Tyr613Phe, confirmed by endocrine test, whole exome sequencing and Sanger sequencing 4 years after onset. The variants located within N-terminal close to the first transmembrane domain of the protein that was highly conserved across different species. Polyphen2 and PROVEAN predicted p.Tyr613Phe to be probably damaging and deleterious. Conclusion: These findings broaden the genetic spectrum of PA and offer novel insights into the molecular mechanisms driving excessive aldosterone production. Therefore, genetic sequencing is recommended for PA patients whose etiology remains unclear after standard clinical evaluation.
Yan et al. (Mon,) conducted a case report in Primary aldosteronism (n=1). CACNA1H mutations (p.His515Tyr and p.Tyr613Phe) was evaluated on Identification of genetic variants. A novel germline CACNA1H mutation (p.Tyr613Phe), predicted to be damaging, was identified in a patient with unilateral adrenal hyperplasia and primary aldosteronism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: